Efficacy and Safety of the PET Imaging Agent [18F]NAV4694 in Subjects With Probable Alzheimer's Disease
Status:
Unknown status
Trial end date:
2018-12-01
Target enrollment:
Participant gender:
Summary
This is a phase 2, open-label, multiple-center, non-randomized single dose study to assess
the safety and efficacy of [18F]NAV4694 PET imaging in detecting beta-amyloid plaque in the
brain in subjects with probable AD compared with healthy volunteers.